IXICO PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.00 GBX | +4.35% |
|
+2.13% | +2.13% |
| 12-10 | Ixico Bags Imaging Services Deal with US Client | MT |
| 12-10 | IXICO plc Wins US Client Clinical Trial Contract | CI |
Company Valuation: IXICO plc
Data adjusted to current consolidation scope
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 45.68 | 38.52 | 16.13 | 9.187 | 4.473 | 11.12 |
| Change | - | -15.67% | -58.13% | -43.05% | -51.32% | 148.64% |
| Enterprise Value (EV) 1 | 37.95 | 32.43 | 10.36 | 5.156 | 2.686 | 8.22 |
| Change | - | -14.53% | -68.05% | -50.24% | -47.91% | 206.1% |
| P/E ratio | 48.5x | 25.6x | 16.5x | -7.79x | -2.23x | -5.71x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.5x | -0.5x | 0x | -0x | 0.1x |
| Capitalization / Revenue | 4.79x | 4.19x | 1.87x | 1.38x | 0.78x | 1.84x |
| EV / Revenue | 3.98x | 3.53x | 1.2x | 0.77x | 0.47x | 1.36x |
| EV / EBITDA | 29.2x | 19.1x | 6.91x | -6.44x | -1.58x | -5.87x |
| EV / EBIT | 44.3x | 27.5x | 11.4x | -3.59x | -1.25x | -4.15x |
| EV / FCF | - | - | - | -3.1x | -1.22x | -3.29x |
| FCF Yield | - | - | - | -32.2% | -82% | -30.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.02 | 0.0312 | 0.0203 | -0.0244 | -0.0414 | -0.021 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 9.532 | 9.19 | 8.643 | 6.665 | 5.766 | 6.05 |
| EBITDA 1 | 1.3 | 1.7 | 1.5 | -0.8 | -1.7 | -1.4 |
| EBIT 1 | 0.856 | 1.181 | 0.908 | -1.437 | -2.154 | -1.983 |
| Net income 1 | 0.952 | 1.575 | 1.035 | -1.178 | -2.001 | -1.783 |
| Net Debt 1 | -7.732 | -6.087 | -5.769 | -4.031 | -1.787 | -2.9 |
| Reference price 2 | 0.9700 | 0.8000 | 0.3350 | 0.1900 | 0.0925 | 0.1200 |
| Nbr of stocks (in thousands) | 47,091 | 48,151 | 48,151 | 48,351 | 48,351 | 92,669 |
| Announcement Date | 12/2/20 | 12/7/21 | 12/7/22 | 12/5/23 | 12/4/24 | - |
1GBP in Million2GBP
Estimates
P/E ratio, Detailed evolution
| P/E ratio | EV / Sales | EV / EBITDA | Yield | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -5.71x | 1.36x | -5.87x | - | 13.56M | ||
| 47.27x | 6.53x | 23.18x | +0.81% | 43.8B | ||
| 26.87x | 3.13x | 13.09x | -.--% | 35.82B | ||
| 89.6x | 11.27x | 40.49x | +0.26% | 26.23B | ||
| 22.74x | 2.29x | 10.96x | -.--% | 16.36B | ||
| 14.55x | 4.82x | 9.25x | -.--% | 16.02B | ||
| -3.63x | 1.67x | -1.5x | -.--% | 13.11B | ||
| 63.12x | 9.76x | 28.03x | +0.42% | 12.05B | ||
| 28.2x | 4.87x | 22.34x | -.--% | 10.46B | ||
| 62.18x | 5.29x | 14.32x | -.--% | 10.22B | ||
| Average | 34.52x | 5.10x | 15.43x | +0.17% | 18.41B | |
| Weighted average by Cap. | 41.45x | 5.72x | 19.40x | +0.26% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- IXI Stock
- Valuation IXICO plc
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition